Dr. Aaron Ellenbogen, DO, MPH
Claim this profileQuest Research Institute
Studies Parkinson's Disease
Studies Alzheimer's Disease
21 reported clinical trials
19 drugs studied
Affiliated Hospitals
Clinical Trials Aaron Ellenbogen, DO, MPH is currently running
Biomarker Database
for Alzheimer's Disease
Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective. Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful relationship exists between biomarkers alone or in combination with tau or amyloid brain pathology identified through PET images.
Recruiting1 award N/A10 criteria
Mevidalen
for Alzheimer's Disease
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Recruiting0 awards Phase 21 criteria
More about Aaron Ellenbogen, DO, MPH
Clinical Trial Related3 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Aaron Ellenbogen, DO, MPH has experience with
- Placebo
- ABP-450
- Donanemab
- Tavapadon
- Buntanetap
- ATH-1017
Breakdown of trials Aaron Ellenbogen, DO, MPH has run
Parkinson's Disease
Alzheimer's Disease
Dementia
Multi-System Atrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aaron Ellenbogen, DO, MPH specialize in?
Aaron Ellenbogen, DO, MPH focuses on Parkinson's Disease and Alzheimer's Disease. In particular, much of their work with Parkinson's Disease has involved treating patients, or patients who are undergoing treatment.
Is Aaron Ellenbogen, DO, MPH currently recruiting for clinical trials?
Yes, Aaron Ellenbogen, DO, MPH is currently recruiting for 2 clinical trials in Farmington Hills Michigan. If you're interested in participating, you should apply.
Are there any treatments that Aaron Ellenbogen, DO, MPH has studied deeply?
Yes, Aaron Ellenbogen, DO, MPH has studied treatments such as Placebo, ABP-450, Donanemab.
What is the best way to schedule an appointment with Aaron Ellenbogen, DO, MPH?
Apply for one of the trials that Aaron Ellenbogen, DO, MPH is conducting.
What is the office address of Aaron Ellenbogen, DO, MPH?
The office of Aaron Ellenbogen, DO, MPH is located at: Quest Research Institute, Farmington Hills, Michigan 48334 United States. This is the address for their practice at the Quest Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.